You are here

Welireg

Arcus' new HIF-2a data in kidney cancer hint at potential edge over Merck's Welireg, analysts say

Fierce Biotech

Thu, 10/24/24 - 08:27 pm

Arcus Biosciences

ESMO: Despite positive trial, Merck's Welireg still comes up short in overall survival

Fierce Pharma

Fri, 09/13/24 - 11:12 am

renal cell carcinoma

clinical trials

Merck partners with HiberCell for Phase Ib renal carcinoma trial

Clinical Trials Arena

Wed, 12/6/23 - 10:29 am

renal cell carcinoma

Merck’s Welireg Clears Phase III Primary Endpoint in Renal Cell Carcinoma

BioSpace

Fri, 08/18/23 - 10:13 am

renal cell carcinoma

clinical trials

Merck's Welireg scores FDA nod in cancers spurred by rare disease—and its label is broader than expected

Fierce Pharma

Sat, 08/14/21 - 01:44 pm

Peloton Therapeutics

von Hippel-Lindau disease